We are live on ! Find out more
RP

Riverbridge Partners Portfolio holdings

AUM $3.58B
1-Year Est. Return 4.02%
This Fund
S&P 500
This Quarter Est. Return
-4.09%
1 Year Est. Return
+4.02%
3 Year Est. Return
+40.43%
5 Year Est. Return
+44.7%
10 Year Est. Return
+473.33%
AUM
$5.13B
AUM Growth
-$607M
Cap. Flow
-$321M
Cap. Flow %
-6.25%
Top 10 Hldgs %
27.89%
Holding
132
New
3
Increased
24
Reduced
88
Closed
5

Top Sells

Rank Stock Value
1
CHE icon
Chemed
CHE
+$56.3M
2
ABAX
Abaxis Inc
ABAX
+$41.4M
3
PRAA icon
PRA Group
PRAA
+$31.6M
4
LOPE icon
Grand Canyon Education
LOPE
+$30.4M
5
EBIX
Ebix Inc
EBIX
+$19.8M

Sector Composition

Rank Sector Weight
1 Technology 24.07%
2 Industrials 19.8%
3 Healthcare 16.31%
4 Consumer Discretionary 10.89%
5 Consumer Staples 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPHD
1
DELISTED
Cepheid Inc
CPHD
$208M 4.05%
4,716,965
-375,558
-7% -$15.8M
ULTI
2
DELISTED
Ultimate Software Group Inc
ULTI
$170M 3.31%
1,200,716
-84,639
-7% -$11.9M
NATI
3
DELISTED
National Instruments Corp
NATI
$152M 2.96%
4,914,203
-370,701
-7% -$12M
ATHN
4
DELISTED
Athenahealth, Inc.
ATHN
$142M 2.77%
1,080,324
+331,598
+44% +$43.7M
RBA icon
5
RB Global
RBA
$21.5B
$141M 2.74%
6,285,386
-377,216
-6% -$8.99M
MD icon
6
Pediatrix Medical
MD
$2.18B
$131M 2.56%
2,395,034
-140,598
-6% -$7.98M
CSGP icon
7
CoStar Group
CSGP
$12B
$123M 2.4%
7,926,850
+1,594,840
+25% +$23.8M
ABCO
8
DELISTED
Advisory Board Co
ABCO
$122M 2.39%
2,626,701
+1,163,250
+79% +$57.4M
PRAA icon
9
PRA Group
PRAA
$678M
$121M 2.36%
2,320,864
-548,808
-19% -$31.6M
MMS icon
10
Maximus
MMS
$3.33B
$120M 2.34%
2,992,377
-241,741
-7% -$10M
UNFI icon
11
United Natural Foods
UNFI
$3.07B
$117M 2.27%
1,895,544
-131,547
-6% -$8.26M
ROL icon
12
Rollins
ROL
$19B
$115M 2.25%
13,309,815
-842,377
-6% -$7.37M
GNTX icon
13
Gentex
GNTX
$5.17B
$113M 2.2%
8,426,182
-589,052
-7% -$8.57M
TRAK
14
DELISTED
DEALERTRACK TECHNOLOGIES, INC. COM STK
TRAK
$108M 2.11%
2,498,920
-175,884
-7% -$7.45M
CHE icon
15
Chemed
CHE
$7.17B
$108M 2.1%
1,045,172
-556,000
-35% -$56.3M
NEOG icon
16
Neogen
NEOG
$1.99B
$96M 1.87%
6,482,605
-493,086
-7% -$7.78M
LOPE icon
17
Grand Canyon Education
LOPE
$4.16B
$94.8M 1.85%
2,325,039
-698,038
-23% -$30.4M
PRLB icon
18
Protolabs
PRLB
$1.72B
$94.5M 1.84%
1,369,871
-100,186
-7% -$7.84M
LKQ icon
19
LKQ Corp
LKQ
$6.75B
$90.6M 1.77%
3,406,759
-194,946
-5% -$5.24M
SRCL
20
DELISTED
Stericycle Inc
SRCL
$87.1M 1.7%
747,166
-52,234
-7% -$6.17M
IHS
21
DELISTED
IHS INC CL-A COM STK
IHS
$86.1M 1.68%
687,414
-49,609
-7% -$6.73M
HCSG icon
22
Healthcare Services Group
HCSG
$1.58B
$85.8M 1.67%
2,998,886
+502,956
+20% +$14M
IPCM
23
DELISTED
IPC HEALTHCARE INC COM DTD
IPCM
$83.7M 1.63%
1,867,656
-145,424
-7% -$6.87M
LLTC
24
DELISTED
Linear Technology Corp
LLTC
$82.2M 1.6%
1,852,877
-92,165
-5% -$4.18M
TECH icon
25
Bio-Techne
TECH
$11.2B
$80.1M 1.56%
3,422,992
-257,092
-7% -$6.03M

Similar funds

Riverbridge Partners's Q3 2014 Portfolio in Review

As of Q3 2014, Riverbridge Partners held 132 positions worth $5.13B, down 11% from $5.74B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Riverbridge Partners withdrew a net $321M in Q3 2014, closing 5 positions and reducing 88 holdings. Its most notable exit was Ebix Inc, an estimated $19.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Riverbridge Partners opened a new position in PROS Holdings worth $23.1M.

  • Riverbridge Partners's largest Q3 2014 buy was PROS Holdings: 915,237 shares worth $23.1M.
  • Riverbridge Partners added most to Advisory Board Co in Q3 2014, an estimated $57.4M increase.
  • Riverbridge Partners's biggest Q3 2014 reduction was Chemed, cutting an estimated $56.3M.
  • Riverbridge Partners fully exited Ebix Inc in Q3 2014, selling an estimated $19.8M.
  • Riverbridge Partners's ten largest holdings make up 28% of its $5.13B portfolio in Q3 2014.
  • Riverbridge Partners opened 3 new positions and closed 5 in Q3 2014.
  • Riverbridge Partners's portfolio value fell 11% quarter-over-quarter to $5.13B.

Based on Riverbridge Partners's 13F filing for Q3 2014, filed 5 Nov 2014.